Skip to main content
Top
Published in: Internal and Emergency Medicine 4/2013

01-06-2013 | IM - ORIGINAL

Prevalence of virulent Helicobacter pylori strains in patients affected by idiopathic dysrhythmias

Authors: Francesco Franceschi, Donatella Brisinda, Francesco Buccelletti, Maria Pia Ruggieri, Antonio Gasbarrini, Annarita Sorbo, Davide Marsiliani, Angela Venuti, Peter Fenici, Giovanni Gasbarrini, Nicolò Gentiloni Silveri, Riccardo Fenici

Published in: Internal and Emergency Medicine | Issue 4/2013

Login to get access

Abstract

Helicobacter pylori virulent strains have been shown to affect cardiovascular diseases through molecular mimicry mechanisms. Silent autoimmune myocarditis has been hypothesized to be the cause of idiopathic dysrhythmias (IA). The aim of this study is to assess the prevalence of virulent H. pylori strains in patients affected by IA. In this study,54 patients (40 men, mean age 44 ± 17 years) affected by IA and 50 healthy subjects (34 men, mean age 45 ± 9) were evaluated. IA, defined as dysrhythmias with no evidence of other cardiac pathology, were either supraventricular (SVA, 23 patients; mean age 45 ± 15 years) or ventricular (VA, 31 patients; mean age 42 ± 18 years). H. pylori infection and gastrointestinal (GI) symptoms were evaluated. H. pylori strains expressing the cytotoxin-associated gene A (cagA) and the vacuolating-cytotoxin A (vacA) were also assessed through western blot. The prevalence of H. pylori is similar in IA patients and in controls (42 vs. 44%; p > 0.05); H. pylori infection is observed in 48 and 39% of the patients are affected by SVA and VA, respectively. The prevalence of CagA-positive strains is increased in IA patients compared to controls (65 vs. 42%; p < 0.01); similarly, the prevalence of VacA-positive strains is also increased in IA patients (74 vs. 46%; p < 0.006). Excluding belching, infected patients did not show any difference in GI symptoms, when compared to non-infected subjects. From this study it is concluded that there is an epidemiological link between CagA and VacA-positive H. pylori strains in IA patients.
Literature
1.
go back to reference Frustaci A, Caldarulo M, Buffon A, Bellocci F, Fenici R, Melina D (1991) Cardiac biopsy in patients with “primary” atrial fibrillation. Chest 100:303–306PubMedCrossRef Frustaci A, Caldarulo M, Buffon A, Bellocci F, Fenici R, Melina D (1991) Cardiac biopsy in patients with “primary” atrial fibrillation. Chest 100:303–306PubMedCrossRef
2.
go back to reference Kumagai K, Akimitsu S, Kawahira K, Kawanami F, Yamanouchi Y, Hiroki T et al (1991) Electrophysiological properties in chronic lone atrial fibrillation. Circulation 84:1662–1668PubMedCrossRef Kumagai K, Akimitsu S, Kawahira K, Kawanami F, Yamanouchi Y, Hiroki T et al (1991) Electrophysiological properties in chronic lone atrial fibrillation. Circulation 84:1662–1668PubMedCrossRef
3.
go back to reference Deal BJ, Miller SM, Scagliotti D, Prechel D, Gallestegni JL, Hariman RJ (1986) Ventricular tachycardia in a young population without overt heart disease. Circulation 73:1111–1118PubMedCrossRef Deal BJ, Miller SM, Scagliotti D, Prechel D, Gallestegni JL, Hariman RJ (1986) Ventricular tachycardia in a young population without overt heart disease. Circulation 73:1111–1118PubMedCrossRef
4.
go back to reference Frustaci A, Bellocci F, Olsen ECJ (1994) Results of biventricular endomyocardial biopsy in survivors of cardiac arrest with apparently normal hearts. Am J Cardiol 74:890–895PubMedCrossRef Frustaci A, Bellocci F, Olsen ECJ (1994) Results of biventricular endomyocardial biopsy in survivors of cardiac arrest with apparently normal hearts. Am J Cardiol 74:890–895PubMedCrossRef
5.
6.
go back to reference Topaz O, Perin E, Cox M, Mallon SM, Castellanos A, Myerburg RJ (1989) Young adult survivors of sudden cardiac arrest: analysis of invasive evaluation of 22 subjects. Am Heart J 118:281–287PubMedCrossRef Topaz O, Perin E, Cox M, Mallon SM, Castellanos A, Myerburg RJ (1989) Young adult survivors of sudden cardiac arrest: analysis of invasive evaluation of 22 subjects. Am Heart J 118:281–287PubMedCrossRef
7.
go back to reference Schoenfeldt MH (1988) The cardiac arrest survivor: lessons from the electrophysiology laboratory. JACC 12:978–981 Schoenfeldt MH (1988) The cardiac arrest survivor: lessons from the electrophysiology laboratory. JACC 12:978–981
8.
go back to reference Lemery R, Brugada P, Della Bella P, Dugernier T, Wellens HJJ (1989) Ventricular fibrillation in six adults without overt heart disease. JACC 13:911–916PubMedCrossRef Lemery R, Brugada P, Della Bella P, Dugernier T, Wellens HJJ (1989) Ventricular fibrillation in six adults without overt heart disease. JACC 13:911–916PubMedCrossRef
9.
go back to reference Mac Arthur CGC, Tarin D, Goodwin JF, Hallidie-Smith KA (1984) The relationship of myocarditis to dilated cardiomyopathy. Eur Heart J 5:1023–1035 Mac Arthur CGC, Tarin D, Goodwin JF, Hallidie-Smith KA (1984) The relationship of myocarditis to dilated cardiomyopathy. Eur Heart J 5:1023–1035
10.
go back to reference Kawai C, Matsumori A, Fujiwara H (1987) Myocarditis and dilated cardiomyopathy. Ann Rev Med 38:221–239PubMedCrossRef Kawai C, Matsumori A, Fujiwara H (1987) Myocarditis and dilated cardiomyopathy. Ann Rev Med 38:221–239PubMedCrossRef
11.
go back to reference De Koster E (1993) Microbiological aspects of Helicobacter pylori. Eur J Gastroenterol. Hepat 5:S33–S35 De Koster E (1993) Microbiological aspects of Helicobacter pylori. Eur J Gastroenterol. Hepat 5:S33–S35
12.
go back to reference Gasbarrini G, Pretolani S, Bonvicini F, Gatto MRA, Tonelli E, Megraud F et al (1995) A population based study of Helicobacter pylori infection in a European country: the San Marino study.Relations with gastrointestinal diseases. Gut 36:838–844PubMedCrossRef Gasbarrini G, Pretolani S, Bonvicini F, Gatto MRA, Tonelli E, Megraud F et al (1995) A population based study of Helicobacter pylori infection in a European country: the San Marino study.Relations with gastrointestinal diseases. Gut 36:838–844PubMedCrossRef
14.
go back to reference Walker MM, Pretolani S, Gasbarrini G (1996) Gastric carcinoma and gastric lymphoma. Curr Opin Gastroenterol. 12(suppl. 1):33–36CrossRef Walker MM, Pretolani S, Gasbarrini G (1996) Gastric carcinoma and gastric lymphoma. Curr Opin Gastroenterol. 12(suppl. 1):33–36CrossRef
15.
go back to reference Moran AP (1996) Pathogenic properties of Helicobacter pylori. Scand J Gastroenterol. 31(suppl):3–10 Moran AP (1996) Pathogenic properties of Helicobacter pylori. Scand J Gastroenterol. 31(suppl):3–10
16.
go back to reference Crabtree JE (1996) Immune and inflammatory response to Helicobacter pylori infection. Scand J Gastroenterol. 31(suppl):3–10CrossRef Crabtree JE (1996) Immune and inflammatory response to Helicobacter pylori infection. Scand J Gastroenterol. 31(suppl):3–10CrossRef
17.
go back to reference Figura N, Tabaqchali S (1996) Bacterial pathogenic factors. Curr Opin Gastroenterol. 12(suppl. 1):33–36 Figura N, Tabaqchali S (1996) Bacterial pathogenic factors. Curr Opin Gastroenterol. 12(suppl. 1):33–36
18.
go back to reference Gasbarrini A, Franceschi F, Gasbarrini G, Pola P (1997) Extraintestinal pathology associated with Helicobacter infection. Eur J Gastroenterol Hepatol 9:231–233PubMedCrossRef Gasbarrini A, Franceschi F, Gasbarrini G, Pola P (1997) Extraintestinal pathology associated with Helicobacter infection. Eur J Gastroenterol Hepatol 9:231–233PubMedCrossRef
19.
go back to reference Gasbarrini A, Serricchio M, Tondi P, Gasbarrini G, Pola P (1996) Association of Helicobacter pylori infection with Raynaud phenomenon. Lancet 348:966–967PubMedCrossRef Gasbarrini A, Serricchio M, Tondi P, Gasbarrini G, Pola P (1996) Association of Helicobacter pylori infection with Raynaud phenomenon. Lancet 348:966–967PubMedCrossRef
20.
go back to reference Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D et al (1994) Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 71:437–439PubMedCrossRef Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D et al (1994) Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 71:437–439PubMedCrossRef
21.
go back to reference Reinauer S, Megahed M, Goerz G, Ruzicka T, Borchard F, Susanto F et al (1995) Schonlein-Henoch purpura associated with gastric Helicobacter pylori infection. J Am Acad Dermatol 33:876–879PubMedCrossRef Reinauer S, Megahed M, Goerz G, Ruzicka T, Borchard F, Susanto F et al (1995) Schonlein-Henoch purpura associated with gastric Helicobacter pylori infection. J Am Acad Dermatol 33:876–879PubMedCrossRef
22.
go back to reference Figura N, Giordano N, Burroni D, Macchia G, Vindigni G, Gennari C et al (1994) Sjogren’s syndrome and Helicobacter pylori infection. Eur J Gastroenterol Hepatol 6:321–322 Figura N, Giordano N, Burroni D, Macchia G, Vindigni G, Gennari C et al (1994) Sjogren’s syndrome and Helicobacter pylori infection. Eur J Gastroenterol Hepatol 6:321–322
23.
go back to reference Pellicano R, Franceschi F, Saracco G, Fagoonee S, Roccarina D, Gasbarrini A (2009) Helicobacters and extragastric diseases. Helicobacter 14(Suppl 1):58–68PubMedCrossRef Pellicano R, Franceschi F, Saracco G, Fagoonee S, Roccarina D, Gasbarrini A (2009) Helicobacters and extragastric diseases. Helicobacter 14(Suppl 1):58–68PubMedCrossRef
24.
go back to reference Franceschi F, Sepulveda AR, Gasbarrini A, Pola P, Silveri NG, Gasbarrini G, Graham DY, Genta RM (2002) Cross-reactivity of anti-CagA antibodies with vascular wall antigens: possible pathogenic link between Helicobacter pylori infection and atherosclerosis. Circulation 106:430–434PubMedCrossRef Franceschi F, Sepulveda AR, Gasbarrini A, Pola P, Silveri NG, Gasbarrini G, Graham DY, Genta RM (2002) Cross-reactivity of anti-CagA antibodies with vascular wall antigens: possible pathogenic link between Helicobacter pylori infection and atherosclerosis. Circulation 106:430–434PubMedCrossRef
25.
go back to reference Bunch TJ, Day JD, Anderson JL, Horne BD, Muhlestein JB, Crandall BG, Weiss JP, Lappe DL, Asirvatham SJ (2008) Frequency of Helicobacter pylori seropositivity and C-reactive protein increase in atrial fibrillation in patients undergoing coronary angiography. Am J Cardiol 101:848–851PubMedCrossRef Bunch TJ, Day JD, Anderson JL, Horne BD, Muhlestein JB, Crandall BG, Weiss JP, Lappe DL, Asirvatham SJ (2008) Frequency of Helicobacter pylori seropositivity and C-reactive protein increase in atrial fibrillation in patients undergoing coronary angiography. Am J Cardiol 101:848–851PubMedCrossRef
26.
go back to reference Andrew P, Montenero AS (2007) Is there a link between atrial fibrillation and certain bacterial infections? J Cardiovasc Med (Hagerstown) 8:990–996CrossRef Andrew P, Montenero AS (2007) Is there a link between atrial fibrillation and certain bacterial infections? J Cardiovasc Med (Hagerstown) 8:990–996CrossRef
27.
go back to reference Badran HM, Mahfouz ME (2007) Cytotoxin-associated gene-A bearing strains of Helicobacter pylori and a trial fibrillation due to ischemic origin: is there a link? Eur J Cardiovasc Prev Rehabil 14:518–520PubMedCrossRef Badran HM, Mahfouz ME (2007) Cytotoxin-associated gene-A bearing strains of Helicobacter pylori and a trial fibrillation due to ischemic origin: is there a link? Eur J Cardiovasc Prev Rehabil 14:518–520PubMedCrossRef
28.
go back to reference Montenero AS, Mollichelli N, Zumbo F, Antonelli A, Dolci A, Barberis M, Sirolla C, Staine T, Fiocca L, Bruno N, O’Connor S (2005) Helicobacter pylori and a trial fibrillation: a possible pathogenic link. Heart 91:960–961PubMedCrossRef Montenero AS, Mollichelli N, Zumbo F, Antonelli A, Dolci A, Barberis M, Sirolla C, Staine T, Fiocca L, Bruno N, O’Connor S (2005) Helicobacter pylori and a trial fibrillation: a possible pathogenic link. Heart 91:960–961PubMedCrossRef
29.
go back to reference Lown B, Calvert AF, Armington R, Ryan M (1975) Monitoring for serious arrhythmias and high risk of sudden death. Circulation 52(6 Suppl):III189–III198PubMed Lown B, Calvert AF, Armington R, Ryan M (1975) Monitoring for serious arrhythmias and high risk of sudden death. Circulation 52(6 Suppl):III189–III198PubMed
30.
go back to reference Negrini R, Savio A, Poiesi C, Appelmelk BJ, Buffoli F, Paterlini A et al (1996) Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis. Gastroenterology 111:655–665PubMedCrossRef Negrini R, Savio A, Poiesi C, Appelmelk BJ, Buffoli F, Paterlini A et al (1996) Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis. Gastroenterology 111:655–665PubMedCrossRef
31.
go back to reference Malfertheiner P, Megraud F, O’Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ (2007) Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 56:772–781PubMedCrossRef Malfertheiner P, Megraud F, O’Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ (2007) Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 56:772–781PubMedCrossRef
32.
go back to reference Herbella FA, Patti MG (2010) Gastroesophageal reflux disease: From pathophysiology to treatment. World J Gastroenterol 16:3745–3749PubMedCrossRef Herbella FA, Patti MG (2010) Gastroesophageal reflux disease: From pathophysiology to treatment. World J Gastroenterol 16:3745–3749PubMedCrossRef
33.
go back to reference Good E, Wells D, Cronin P, Morady F, Oral H (2008) Images in cardiovascular medicine.Massive hiatal hernia and thoracic stomach illustrated by barium swallow during left atrial catheter ablation for a trial fibrillation. Circulation 118:2011–2012PubMedCrossRef Good E, Wells D, Cronin P, Morady F, Oral H (2008) Images in cardiovascular medicine.Massive hiatal hernia and thoracic stomach illustrated by barium swallow during left atrial catheter ablation for a trial fibrillation. Circulation 118:2011–2012PubMedCrossRef
Metadata
Title
Prevalence of virulent Helicobacter pylori strains in patients affected by idiopathic dysrhythmias
Authors
Francesco Franceschi
Donatella Brisinda
Francesco Buccelletti
Maria Pia Ruggieri
Antonio Gasbarrini
Annarita Sorbo
Davide Marsiliani
Angela Venuti
Peter Fenici
Giovanni Gasbarrini
Nicolò Gentiloni Silveri
Riccardo Fenici
Publication date
01-06-2013
Publisher
Springer Milan
Published in
Internal and Emergency Medicine / Issue 4/2013
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-011-0621-8

Other articles of this Issue 4/2013

Internal and Emergency Medicine 4/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine